These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19751436)
1. Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients. Wang X; Yang J; Ho B; Yang Y; Huang Z; Zhang Z; Zhang G Helicobacter; 2009 Oct; 14(5):114-9. PubMed ID: 19751436 [TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients. Pan X; Li Y; Feng J; Wang X; Hao B; Shi R; Zhang G BMC Cancer; 2013 Mar; 13():126. PubMed ID: 23506213 [TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection and MDM2 SNP309 association with gastric cancer susceptibility. Moradi MT; Salehi Z; Asl SF; Aminian K; Hashtchin AR Genet Test Mol Biomarkers; 2013 Nov; 17(11):794-8. PubMed ID: 24010568 [TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphism of MDM2 SNP309 in Patients with Helicobacter Pylori-Associated Gastritis. Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S Asian Pac J Cancer Prev; 2015; 16(16):7049-52. PubMed ID: 26514489 [TBL] [Abstract][Full Text] [Related]
5. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539 [TBL] [Abstract][Full Text] [Related]
6. Role of screening colonoscopy for colorectal tumors in Helicobacter pylori-related chronic gastritis with MDM2 SNP309 G/G homozygous: A prospective cross-sectional study in Thailand. Tongtawee T; Simawaranon T; Wattanawongdon W Turk J Gastroenterol; 2018 Sep; 29(5):555-560. PubMed ID: 30260777 [TBL] [Abstract][Full Text] [Related]
7. MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis. Ma Y; Bian J; Cao H PLoS One; 2013; 8(2):e56918. PubMed ID: 23451111 [TBL] [Abstract][Full Text] [Related]
8. A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer. Nan H; Qureshi AA; Hunter DJ; Han J Cancer Causes Control; 2009 Mar; 20(2):171-9. PubMed ID: 18814047 [TBL] [Abstract][Full Text] [Related]
9. MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. Ohmiya N; Taguchi A; Mabuchi N; Itoh A; Hirooka Y; Niwa Y; Goto H J Clin Oncol; 2006 Sep; 24(27):4434-40. PubMed ID: 16983111 [TBL] [Abstract][Full Text] [Related]
10. MDM2 SNP309 polymorphism is associated with colorectal cancer risk. Wang W; Du M; Gu D; Zhu L; Chu H; Tong N; Zhang Z; Xu Z; Wang M Sci Rep; 2014 May; 4():4851. PubMed ID: 24797837 [TBL] [Abstract][Full Text] [Related]
11. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL. Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873 [TBL] [Abstract][Full Text] [Related]
12. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer. Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369 [TBL] [Abstract][Full Text] [Related]
13. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. Wan Y; Wu W; Yin Z; Guan P; Zhou B BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population. Ma H; Hu Z; Zhai X; Wang S; Wang X; Qin J; Jin G; Liu J; Wang X; Wei Q; Shen H Cancer Lett; 2006 Aug; 240(2):261-7. PubMed ID: 16288830 [TBL] [Abstract][Full Text] [Related]
15. Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population. Hu Z; Ma H; Lu D; Qian J; Zhou J; Chen Y; Xu L; Wang X; Wei Q; Shen H Int J Cancer; 2006 Mar; 118(5):1275-8. PubMed ID: 16152608 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population. Zhang X; Zheng L; Sun Y; Zhang X Tumour Biol; 2014 Feb; 35(2):1575-80. PubMed ID: 24218334 [TBL] [Abstract][Full Text] [Related]
17. MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma. Xiao FK; Guo S; Yang F; Zhao LS; Wang LD J Gene Med; 2019 May; 21(5):e3086. PubMed ID: 30861607 [TBL] [Abstract][Full Text] [Related]
18. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Zhou G; Zhai Y; Cui Y; Zhang X; Dong X; Yang H; He Y; Yao K; Zhang H; Zhi L; Yuan X; Qiu W; Zhang X; Shen Y; Qiang B; He F Clin Cancer Res; 2007 May; 13(9):2627-33. PubMed ID: 17473193 [TBL] [Abstract][Full Text] [Related]
19. Effects of p53 codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population. Moradi MT; Salehi Z; Aminian K; Yazdanbod A Asian Pac J Cancer Prev; 2014; 15(17):7413-7. PubMed ID: 25227851 [TBL] [Abstract][Full Text] [Related]
20. Role of the Mdm2 SNIP 309 Polymorphism in Gastric Mucosal Morphologic Patterns of Patients with Helicobacter pylori Associated Gastritis. Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S Asian Pac J Cancer Prev; 2016; 17(3):1057-60. PubMed ID: 27039725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]